Faro Molecular is developing a next generation, highly multiplexed platform for bio-medical and diagnostic applications. Key features of this platform include a rapid time to result, low cost, ease of use all while multiplexing hundreds of targets per sample.

We are targeting applications in R&D for molecular selections (aptamers, DNA encoded libraries, NGS library preparation) as well as in diagnostics (epigenetic marker quantification for oncology and diseases related to aging).

The Faro team includes individuals with decades of experience developing PCR platforms for industry leading companies.